Nu-Med Plus (NUMD) Change in Accured Expenses (2012 - 2025)
Nu-Med Plus (NUMD) posted Change in Accured Expenses of $2625.0 for Q4 2025, up 38.82% sequentially from $1891.0 in Q3 2025, and up 212.47% YoY from $840.09 in Q4 2024.
Nu-Med Plus (NUMD) Change in Accured Expenses (2012 - 2025) Analysis & Trends
Nu-Med Plus has reported Change in Accured Expenses for 14 years, with the latest figure at $2625.0 in Q4 2025.
- Quarterly Change in Accured Expenses rose 212.47% year-over-year to $2625.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3290.0 (down 62.27% YoY) and the FY2025 annual result came in at $3290.0, down 62.27% from the prior year.
- Change in Accured Expenses climbed to $2625.0 in Q4 2025 per NUMD's latest filing, from $1891.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $62945.0 in Q4 2022 and troughed at -$6254.0 in Q2 2025.
- A 5-year average of $9924.5 and a median of $4787.0 in 2024 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2021 and 2024: Change in Accured Expenses soared 596.76% in 2021, then slumped 285.24% in 2024.
- Over 5 years, Change in Accured Expenses stood at $21493.0 in 2021, then soared by 192.86% to $62945.0 in 2022, then tumbled by 98.0% to $1260.0 in 2023, then plunged by 285.24% to -$2334.0 in 2024, then surged by 212.47% to $2625.0 in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $2625.0, $1891.0, and -$6254.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,625.00 |
| Dec 31, 2025 | 2,625.00 |
| Sep 30, 2025 | 1,891.00 |
| Sep 30, 2025 | 1,891.00 |
| Jun 30, 2025 | -6,254.00 |
| Jun 30, 2025 | -6,254.00 |
| Mar 31, 2025 | 5,028.00 |
| Mar 31, 2025 | 5,028.00 |
| Dec 31, 2024 | -2,334.00 |
| Dec 31, 2024 | -2,334.00 |
| Sep 30, 2024 | -2,040.00 |
| Sep 30, 2024 | -2,040.00 |
| Jun 30, 2024 | 4,546.00 |
| Jun 30, 2024 | 4,546.00 |
| Mar 31, 2024 | 8,547.00 |
| Mar 31, 2024 | 8,547.00 |
| Dec 31, 2023 | 1,260.00 |
| Dec 31, 2023 | 1,260.00 |
| Sep 30, 2023 | 1,261.00 |
| Sep 30, 2023 | 1,261.00 |